1. US Renal Data System. 2022 USRDS Annual Data Report: epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2022.
2. SGLT2 inhibitors for the treatment of diabetes: a patent review (2013-2018);Pandey;Expert Opin Ther Pat,2019
3. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes;DeFronzo;Diabetes Care,2005
4. KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease;Am J Kidney Dis,2007
5. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease;Kidney Int,2020